Laurence Albiges, MD, PhD Institut Gustave Roussy Villejuif, France gives an overview of TiNivo A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma at the 2017 Kidney Cancer Association symposium in Miami, FL.
TiNivo A Phase Ib Dose Escalation Trial of Tivozanib and Nivolumab in Renal Cell Carcinoma
